Yuria-Pharm   Report issue

For profit Phase 4
Founded: Kyiv Ukraine (1968)
Status: No NME R&D (1968)

Organization Overview

First Clinical Trial
2016
NCT03764085
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Yuria-Pharm

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Burns (Phase 4)

Peritonitis (Phase 4)

Pneumonia (Phase 4)

Sepsis (Phase 4)

Toxemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6